“Deucravacitinib in moderate to severe plaque psoriasis: liver transaminase results from the phase 3 POETYK PSO program” (2023) SKIN The Journal of Cutaneous Medicine, 7(2), p. s116. doi:10.25251/skin.7.supp.116.